Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.

Menezes HZ, Shadlen KC

DOI: 10.1590/0102-311xen052426
Published: 2026
Container: Cadernos de saude publica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1590/0102-311xen052426,
  title = {Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.},
  author = {Menezes HZ and Shadlen KC},
  year = {2026},
  journal = {Cadernos de saude publica},
  doi = {10.1590/0102-311xen052426},
  url = {https://doi.org/10.1590/0102-311xen052426}
}

RIS

TY  - JOUR
TI  - Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.
AU  - Menezes HZ
AU  - Shadlen KC
PY  - 2026
JO  - Cadernos de saude publica
DO  - 10.1590/0102-311xen052426
UR  - https://doi.org/10.1590/0102-311xen052426
ER  -

APA

HZ, M., & KC, S. (2026). Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.. Cadernos de saude publica. https://doi.org/10.1590/0102-311xen052426

Source records

pubmed · retrieved 2026-11-10T14:11:18.394Z